跳至主要内容
临床试验/NCT06164808
NCT06164808招募中不适用

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

HelpWear Inc.2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年2月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
HelpWear Inc.
入组人数
300
试验地点
2
主要终点
QRS signal detection

研究概览

简要总结

Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.

详细描述

Patients who are being referred to wear a holter monitor will be approached to wear a HeartWatch simultaneously. This will allow collection of signals on both devices and to compare the accuracy of signals between the Heartwatch vs Holter monitor. It will also examine the reliability of autodetect algorythms between the devices. We will also collect information to compare the amount of adverse events between the various systems and the patient preference of those systems.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 22 years of age at time of consent
  • Clinically indicated for a Holter monitor test
  • Able to wear the HeartWatch on the left bicep for the study duration
  • Able to follow the protocol
  • No functional implantable pacemaker or defibrillator
  • Left bicep circumference >/= 22 cm and </= 45 cm
  • Provision of written-informed consent

排除标准

  • Known allergy to any component of the Holter monitor
  • Known allergy to any component of the HeartWatch
  • Inability to wear the HeartWatch on the left arm for the study period due to pre-existing medical condition (3.g., functional AV fistula in left arm, prior carcinoma with lymph node dissection or lymphedema, known blood clot of recurrent blood clots in the left arm, chronic neuropathic pain in left arm, ...)
  • Dextrocardia
  • Implanted functional Pacemaker or Defibrillator
  • Left bicep circumference < 22 cm
  • Left bicep circumference < 45 cm

研究组 & 干预措施

Active device engagement

Other

All subjects will wear either the Holter monitor and the HeartWatch.

干预措施: HeartWatch (Device)

结局指标

主要结局

QRS signal detection

时间窗: For the duration of time that the patient wears the Holter monitor and the HeartWatch, 24-48 hours

Compare QRS detection accuracy with HeartWatch data vs. the Holter monitor lead I signal

次要结局

  • ECG PR interval assessment(For the duration of time that the subject wears the holter vs the HeartWatch (24-48 hours).)
  • ECG QRS interval assessment(For the duration of time that the subject wears the holter vs the HeartWatch (24-48 hours).)
  • ECG strip evaluation(For the duration of time that the subject wears the holter vs the HeartWatch (24-48 hours).)
  • ECG interval assessment(For the duration of time that the subject wears the holter vs the HeartWatch (24-48 hours).)

研究者

发起方
HelpWear Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验